CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Jun. 28, 2013		Jun. 29, 2012
Cash flows from operating activities:
Net earnings	$ 320,902		$ 306,848
Adjustments to reconcile net earnings to net cash provided by operating activities:
Share-based compensation expense	33,915		36,655
Tax benefits from exercises of share-based payment awards	10,407		6,647
Excess tax benefits from share-based compensation	(9,570)		(7,805)
Depreciation	44,614		39,711
Amortization of intangible assets	3,295		2,848
Deferred taxes	5,130		(275)
Provision for doubtful accounts receivable	4,814		6,240
Income on equity investment in affiliate	(2,459)		(1,225)
Other, net	(908)		(858)
Changes in assets and liabilities, net of effect of acquisitions:
Accounts receivable	18,663		(4,170)
Inventories	(80,398)		(49,271)
Prepaid expenses and other current assets	(22,637)		(47,665)
Accounts payable	(261)		(7,668)
Accrued expenses	(73,781)		(10,574)
Deferred revenues	22,481		(16,992)
Product warranty	(1,779)		4
Advance payments from customers	30,303		54,823
Other long-term liabilities	(2,475)		(5,911)
Net cash provided by operating activities	300,256		301,362
Cash flows from investing activities:
Purchases of property, plant and equipment	(56,688)		(40,188)
Investment in debt security	(7,554)		(27,950)
Acquisition of businesses, net of cash acquired			(28,241)
Net amounts paid to deferred compensation plan (“DCP”) trust account	(15)		(2,708)
Note repayments/(receivable) from other and affiliate, respectively	(10,000)		3,360
Other, net	(129)		(2,340)
Net cash used in investing activities	(74,386)		(98,067)
Cash flows from financing activities:
Repurchases of common stock	(289,099)		(172,418)
Proceeds from issuance of common stock to employees	104,464		54,529
Excess tax benefits from share-based compensation	9,570		7,805
Employees’ taxes withheld and paid for restricted stock and restricted stock units	(9,526)		(8,598)
Net borrowings/(repayments) under line of credit agreements	14,935		(12,585)
Repayments of bank borrowings			(9,876)
Other, net	(935)		(74)
Net cash used in financing activities	(170,591)		(141,217)
Effects of exchange rate changes on cash and cash equivalents	5,718		6,851
Net increase in cash and cash equivalents	60,997		68,929
Cash and cash equivalents at beginning of period	704,570	[1]	564,457
Cash and cash equivalents at end of period	$ 765,567		$ 633,386

[1] The condensed consolidated balance sheet as of September 28, 2012 was derived from audited financial statements as of that date, but does not include all disclosures required by accounting principles generally accepted in the United States of America.